Colorectal Cancer Metastatic Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
Colorectal Cancer Metastatic
Chinese PLA General Hospital30 enrolled1 locationNCT07044921
Recruiting
Phase 2
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Dai, Guanghai46 enrolled1 locationNCT06685276